Related references
Note: Only part of the references are listed.Risk Factors of Subsequent Central Nervous System Tumors after Childhood and Adolescent Cancers: Findings from the French Childhood Cancer Survivor Study
Neige Marie Yvanne Journy et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2021)
Insights from the clinical phenotype of subjects with Laron syndrome in Ecuador
Jaime Guevara-Aguirre et al.
REVIEWS IN ENDOCRINE & METABOLIC DISORDERS (2021)
Mammary Tumors Growing in the Absence of Growth Hormone Are More Sensitive to Doxorubicin Than Wild-Type Tumors
Daniel D. Lantvit et al.
ENDOCRINOLOGY (2021)
Sensitivity and specificity of the macimorelin test for diagnosis of AGHD
Jose M. Garcia et al.
ENDOCRINE CONNECTIONS (2021)
Growth hormone deficiency in adults with hypopituitarism-What are the risks and can they be eliminated by therapy?
Gudmundur Johannsson et al.
JOURNAL OF INTERNAL MEDICINE (2021)
The growth rate and clinical outcomes of radiation induced meningioma undergoing treatment or active monitoring
Conor S. Gillespie et al.
JOURNAL OF NEURO-ONCOLOGY (2021)
Safety of growth hormone (GH) treatment in GH deficient children and adults treated for cancer and non-malignant intracranial tumors-a review of research and clinical practice
Margaret C. S. Boguszewski et al.
PITUITARY (2021)
Growth Hormone Therapy Does Not Increase the Risk of Craniopharyngioma and Nonfunctioning Pituitary Adenoma Recurrence
Marco Losa et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2020)
Heterogeneity of Growth Hormone Receptor Expression in Craniopharyngioma? Implications for Surgical Strategy
Yoshikazu Ogawa et al.
WORLD NEUROSURGERY (2020)
Influence of growth hormone therapy on the occurrence of a second neoplasm in survivors of childhood cancer
Cecile Thomas-Teinturier et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2020)
Thyroid and colorectal cancer screening in acromegaly patients: should it be different from that in the general population?
Massimo Terzolo et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2020)
Safety of current recombinant human growth hormone treatments for adults with growth hormone deficiency and unmet needs
Charlotte Hoybye et al.
EXPERT OPINION ON DRUG SAFETY (2020)
Role of the GH-IGF1 system in progression of cancer
Haim Werner et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2020)
Growth Hormone Upregulates Mediators of Melanoma Drug Efflux and Epithelial-to-Mesenchymal Transition In Vitro and In Vivo
Yanrong Qian et al.
CANCERS (2020)
Laron Syndrome Research Paves the Way for New Insights in Oncological Investigation
Haim Werner et al.
CELLS (2020)
Risk of Meningioma in European Patients Treated With Growth Hormone in Childhood: Results From the SAGhE Cohort
Anthony J. Swerdlow et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2019)
Risk of benign meningioma after childhood cancer in the DCOG-LATER cohort: contributions of radiation dose, exposed cranial volume, and age
Judith L. Kok et al.
NEURO-ONCOLOGY (2019)
Diagnosis, Genetics, and Therapy of Short Stature in Children: A Growth Hormone Research Society International Perspective
Paulo F. Collett-Solberg et al.
HORMONE RESEARCH IN PAEDIATRICS (2019)
Hypothalamic-Pituitary Disorders in Childhood Cancer Survivors: Prevalence, Risk Factors and Long-Term Health Outcomes
Laura van Iersel et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2019)
AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY GUIDELINES FOR MANAGEMENT OF GROWTH HORMONE DEFICIENCY IN ADULTS AND PATIENTS TRANSITIONING FROM PEDIATRIC TO ADULT CARE 2019 AACE GROWTH HORMONE TASK FORCE
Kevin C. J. Yuen et al.
ENDOCRINE PRACTICE (2019)
Genetic susceptibility to radiation-induced breast cancer after Hodgkin lymphoma
Annemieke W. J. Opstal-van Winden et al.
BLOOD (2019)
Growth Hormone's Links to Cancer
Cesar Luiz Boguszewski et al.
ENDOCRINE REVIEWS (2019)
Underdiagnosis of Hereditary Breast Cancer: Are Genetic Testing Guidelines a Tool or an Obstacle?
Peter D. Beitsch et al.
JOURNAL OF CLINICAL ONCOLOGY (2019)
Excess growth hormone suppresses DNA damage repair in epithelial cells
Vera Chesnokova et al.
JCI INSIGHT (2019)
Growth hormone in the tumor microenvironment
Vera Chesnokova et al.
ARCHIVES OF ENDOCRINOLOGY METABOLISM (2019)
Lessons from growth hormone receptor gene-disrupted mice: are there benefits of endocrine defects?
Reetobrata Basu et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2018)
Occurrence of neoplasms in individuals with congenital, severe GH deficiency from the Itabaianinha kindred
Cindi G. Marinho et al.
GROWTH HORMONE & IGF RESEARCH (2018)
Hypothalamic-Pituitary and Growth Disorders in Survivors of Childhood Cancer: An Endocrine Society* Clinical Practice Guideline
Charles A. Sklar et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2018)
GH Therapy in Childhood Cancer Survivors: A Systematic Review and Meta-Analysis
Shrikant Tamhane et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2018)
Growth Hormone Research Society perspective on biomarkers of GH action in children and adults
Gudmundur Johannsson et al.
ENDOCRINE CONNECTIONS (2018)
Complications of acromegaly: thyroid and colon
Amit Tirosh et al.
PITUITARY (2017)
Neuroendocrine surveillance and management of neurosurgical patients
Aoife Garrahy et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2017)
Temporal Trends in Treatment and Subsequent Neoplasm Risk Among 5-Year Survivors of Childhood Cancer, 1970-2015
Lucie M. Turcotte et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2017)
Cancer Risks in Patients Treated With Growth Hormone in Childhood: The SAGhE European Cohort Study
Anthony J Swerdlow et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2017)
Tumour-Derived Human Growth Hormone As a Therapeutic Target in Oncology
Jo K. Perry et al.
TRENDS IN ENDOCRINOLOGY AND METABOLISM (2017)
Growth Hormone Receptor Knockdown Sensitizes Human Melanoma Cells to Chemotherapy by Attenuating Expression of ABC Drug Efflux Pumps
Reetobrata Basu et al.
HORMONES & CANCER (2017)
The GH/IGF-1 axis in a critical period early in life determines cellular DNA repair capacity by altering transcriptional regulation of DNA repair-related genes: implications for the developmental origins of cancer
Andrej Podlutsky et al.
GEROSCIENCE (2017)
GH safety workshop position paper: a critical appraisal of recombinant human GH therapy in children and adults
D. B. Allen et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2016)
Acromegaly and cancer: an old debate revisited
Cesar Luiz Boguszewski et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2016)
Growth Hormone Research Society perspective on the development of long-acting growth hormone preparations
Jens Sandahl Christiansen et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2016)
Acromegaly incidence, prevalence, complications and long-term prognosis: a nationwide cohort study
Jakob Dal et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2016)
Guidelines for Growth Hormone and Insulin-Like Growth Factor-I Treatment in Children and Adolescents: Growth Hormone Deficiency, Idiopathic Short Stature, and Primary Insulin-Like Growth Factor-I Deficiency
Adda Grimberg et al.
HORMONE RESEARCH IN PAEDIATRICS (2016)
Hormonal Replacement in Hypopituitarism in Adults: An Endocrine Society Clinical Practice Guideline
Maria Fleseriu et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2016)
Recognizing Endocrinopathies Associated With Tyrosine Kinase Inhibitor Therapy in Children With Chronic Myelogenous Leukemia
Jill Samis et al.
PEDIATRIC BLOOD & CANCER (2016)
Revised GH and cortisol cut-points for the glucagon stimulation test in the evaluation of GH and hypothalamic-pituitary-adrenal axes in adults: results from a prospective randomized multicenter study
Amir H. Hamrahian et al.
PITUITARY (2016)
Introduction to cancer genetic susceptibility syndromes
Rose B. McGee et al.
HEMATOLOGY-AMERICAN SOCIETY OF HEMATOLOGY EDUCATION PROGRAM (2016)
Is there a role for IGF-1 in the development of second primary cancers?
Thurkaa Shanmugalingam et al.
CANCER MEDICINE (2016)
Cancer spectrum and frequency among children with Noonan, Costello, and cardio-facio-cutaneous syndromes
C. P. Kratz et al.
BRITISH JOURNAL OF CANCER (2015)
Incidence of primary cancers and intracranial tumour recurrences in GH-treated and untreated adult hypopituitary patients: analyses from the Hypopituitary Control and Complications Study
Christopher J. Child et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2015)
Autocrine/paracrine roles of extrapituitary growth hormone and prolactin in health and disease: An overview
Steve Harvey et al.
GENERAL AND COMPARATIVE ENDOCRINOLOGY (2015)
Risk of Neoplasia in Pediatric Patients Receiving Growth Hormone Therapy-A Report From the Pediatric Endocrine Society Drug and Therapeutics Committee
Sripriya Raman et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2015)
Anterior Hypopituitarism in Adult Survivors of Childhood Cancers Treated With Cranial Radiotherapy: A Report From the St Jude Lifetime Cohort Study
Wassim Chemaitilly et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
The Efficacy and Safety of Growth Hormone Therapy in Children with Noonan Syndrome: A Review of the Evidence
Jacqueline A. Noonan et al.
HORMONE RESEARCH IN PAEDIATRICS (2015)
Insulin- like growth factor I and risk of breast cancer by age and hormone receptor status- A prospective study within the EPIC cohort
Rudolf Kaaks et al.
INTERNATIONAL JOURNAL OF CANCER (2014)
Overweight/Obese Adults With Pituitary Disorders Require Lower Peak Growth Hormone Cutoff Values on Glucagon Stimulation Testing to Avoid Overdiagnosis of Growth Hormone Deficiency
Laura E. Dichtel et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2014)
Growth Hormone Exposure as a Risk Factor for the Development of Subsequent Neoplasms of the Central Nervous System: A Report From the Childhood Cancer Survivor Study
Briana C. Patterson et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2014)
The key role of growth hormone-insulin-IGF-1 signaling in aging and cancer
Vladimir N. Anisimov et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2013)
American Association of Clinical Endocrinologists Medical Guidelines for Clinical Practice for Growth Hormone Use in Growth Hormone-Deficient Adults and Transition Patients - 2009 Update
David Cook et al.
Endocrine Practice (2013)
Incidence of second neoplasm in childhood cancer survivors treated with GH: an analysis of GeNeSIS and HypoCCS
Whitney W. Woodmansee et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2013)
Prospective Safety Surveillance of GH-Deficient Adults: Comparison of GH-Treated vs Untreated Patients
Mark L. Hartman et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2013)
Bloom Syndrome in Short Children Born Small for Gestational Age: A Challenging Diagnosis
Judith S. Renes et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2013)
Craniopharyngioma cell growth is promoted by growth hormone (GH) and is inhibited by tamoxifen: Involvement of growth hormone receptor (GHR) and IGF-1 receptor (IGF-1R)
Qiang Li et al.
JOURNAL OF CLINICAL NEUROSCIENCE (2013)
Insulin and IGFs in Obesity-Related Breast Cancer
Valentina Belardi et al.
JOURNAL OF MAMMARY GLAND BIOLOGY AND NEOPLASIA (2013)
Subsequent neoplasms of the CNS among survivors of childhood cancer: a systematic review
Daniel C. Bowers et al.
LANCET ONCOLOGY (2013)
Growth failure in children with chronic myeloid leukemia receiving imatinib is due to disruption of GH/IGF-1 axis
Karthik R. Narayanan et al.
PEDIATRIC BLOOD & CANCER (2013)
Dietary glycemic index and glycemic load and breast cancer risk in the European Prospective Investigation into Cancer and Nutrition (EPIC)
Isabelle Romieu et al.
AMERICAN JOURNAL OF CLINICAL NUTRITION (2012)
Patient with a neurofibromatosis type 1 mutation but a clinical diagnosis of Noonan syndrome
Ellen A. Croonen et al.
CLINICAL DYSMORPHOLOGY (2012)
Tumour recurrence and enlargement in patients with craniopharyngioma with and without GH replacement therapy during more than 10 years of follow-up
D. S. Olsson et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2012)
A review of guidelines for use of growth hormone in pediatric and transition patients
David M. Cook et al.
PITUITARY (2012)
A cross-sectional analysis of the associations between adult height, BMI and serum concentrations of IGF-I and IGFBP-1-2 and-3 in the European Prospective Investigation into Cancer and Nutrition (EPIC)
Francesca L. Crowe et al.
ANNALS OF HUMAN BIOLOGY (2011)
Congenital IGF1 deficiency tends to confer protection against post-natal development of malignancies
Rachel Steuerman et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2011)
Evaluation and Treatment of Adult Growth Hormone Deficiency: An Endocrine Society Clinical Practice Guideline
Mark E. Molitch et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2011)
Pituitary Dysfunction in Adult Patients after Cranial Radiotherapy: Systematic Review and Meta-Analysis
Natasha M. Appelman-Dijkstra et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2011)
Long-Term Safety of Growth Hormone Replacement after CNS Irradiation
S. Mackenzie et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2011)
Effects of Growth Hormone Therapy on Bone Mass, Metabolic Balance, and Well-Being in Young Adult Survivors of Childhood Acute Lymphoblastic Leukemia
Silvia van den Heijkant et al.
JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY (2011)
Pathway Analysis of Breast Cancer Genome-Wide Association Study Highlights Three Pathways and One Canonical Signaling Cascade
Idan Menashe et al.
CANCER RESEARCH (2010)
Cardiovascular Risk, Cardiac Function, Physical Activity, and Quality of Life with and without Long-Term Growth Hormone Therapy in Adult Survivors of Childhood Acute Lymphoblastic Leukemia
Cecilia Follin et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2010)
Hormone Receptor Expression in Craniopharyngiomas: A Clinicopathological Correlation
Bernd M. Hofmann et al.
NEUROSURGERY (2010)
GH replacement in patients with non-functioning pituitary adenoma (NFA) treated solely by surgery is not associated with increased risk of tumour recurrence
J. R. Arnold et al.
CLINICAL ENDOCRINOLOGY (2009)
Comparing progression of non-functioning pituitary adenomas in hypopituitarism patients with and without long-term GH replacement therapy
D. S. Olsson et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2009)
Reassessment of the Growth Hormone Status in Young Adults with Childhood-Onset Growth Hormone Deficiency: Reappraisal of Insulin Tolerance Testing
Andrea Secco et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2009)
Advanced rat mammary cancers are growth hormone dependent
Qi Shen et al.
ENDOCRINOLOGY (2007)
Approach to the growth hormone-deficient child during transition to adulthood
Sally Radovick et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2007)
Recurrence of brain tumours in patients treated with growth hormone: Analysis of KIGS (Pfizer International Growth Database)
Feyza Darendeliler et al.
ACTA PAEDIATRICA (2006)
Growth hormone treatment and risk of second neoplasms in the childhood cancer survivor
Berrin Ergun-Longmire et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2006)
IGF-1, IGFBP-3 and breast cancer risk in women:: The European Prospective Investigation into Cancer and Nutrition (EPIC)
S. Rinaldi et al.
ENDOCRINE-RELATED CANCER (2006)
GH replacement does not increase the risk of recurrence in patients with craniopharyngioma
N Karavitaki et al.
CLINICAL ENDOCRINOLOGY (2006)
Consensus statement on the management of the GH-treated adolescent in the transition to adult care
PE Clayton et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2005)
Outcomes of growth hormone replacement therapy in survivors of childhood acute lymphoblastic leukemia
W Leung et al.
JOURNAL OF CLINICAL ONCOLOGY (2002)
Growth hormone replacement therapy in children with medulloblastoma: Use and effect on tumor control
RJ Packer et al.
JOURNAL OF CLINICAL ONCOLOGY (2001)